KPTI
Karyopharm Therapeutics Inc.
$5.41
-$0.32(-5.58%)
31
Overall
--
Value
18
Tech
44
Quality
Market Cap
$54.28M
Volume
174.06K
52W Range
$3.51 - $16.95
Target Price
$17.60
EPS Estimates Overview
| Current Quarter | $-3.67 | Next Quarter | $-3.02 |
| Current Year | $-12.84 | Next Year | $-9.98 |
| QoQ Growth | +17.7% | YoY Growth | +22.3% |
| 3Y EPS CAGR | +70.6% | Target Price | $17.60 |
| Consensus | Buy | Upside | +225.3% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | KPTI | $5.41 | -5.6% | 174.06K |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Karyopharm Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW